dacarbazine has been researched along with Neoplasms, Vascular in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, JL; Grignol, V; Politano, S; Pollock, RE; Squires, MH | 1 |
Madlon-Kay, R; Patel, M; Raza, A; Skubitz, K; Vakil, K; Zakharova, M | 1 |
Delaunay, M; Jouary, T; Taieb, A | 1 |
3 other study(ies) available for dacarbazine and Neoplasms, Vascular
Article | Year |
---|---|
Modern multimodality management of patients with caval leiomyosarcoma: New treatment paradigms and potential molecular insights.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Leiomyosarcoma; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Retroperitoneal Neoplasms; Retrospective Studies; Vascular Neoplasms; Vena Cava, Inferior | 2021 |
An absolute obstacle: cardiac metastasis of synovial sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Deoxycytidine; Disease Progression; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fatal Outcome; Gemcitabine; Heart Atria; Heart Neoplasms; Humans; Ifosfamide; Male; Polyethylene Glycols; Sarcoma, Synovial; Shoulder; Treatment Failure; Treatment Refusal; Vascular Neoplasms; Vena Cava, Superior | 2014 |
Hematoma-like metastases.
Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain; Dacarbazine; Diagnosis, Differential; Fatal Outcome; Hematoma; Hemorrhage; Humans; Liver Neoplasms; Male; Melanoma; Muscle Neoplasms; Paresis; Skin; Skin Neoplasms; Vascular Neoplasms | 2006 |